A prospective randomised clinical study comparing the functional perfo
rmance and biocompatibility of a new cellulose diacetate variant (Dice
a) in which the degree of hydroxyl group substitution differes, with c
ellulose diacetate and low flux polysulfone incorporated into commerci
ally produced hollow fiber hemodialysers with a surface area 1.5-1.6 m
(2) has been undertaken. All dialysers studied demonstrated clinically
acceptable performance in terms of their small molecular removal char
acteristics, with minor statistical but not clinical differences. Use
of both cellulose diacetate membranes but not low flux polysulfone res
ulted in a reduction in plasma beta(2) microglobulin levels. The membr
anes were impermeable to albumin, but showed some permeability to low
molecular weight proteins. The average protein recovery from the dialy
sis fluid was 3105 mg for Dicea, 2913 mg for cellulose diacetate and 2
842 mg for low flux polysulfone. For Dicea the white cell count by 15
minutes had declined to 68% of pre treatment value, compared with 59%
and 86% for cellulose diacetate and low flux polysulfone. The differen
ces between Dicea and cellulose diacetate were not significant, but bo
th cellulose based membranes differed from low flux polysulfone (p = 0
.0015). There was a strong evidence of differences between the membran
es in respect of C5a and C5b-9 generation (p = 0.0001) but not for C3a
(p = 0.16) furthermore the levels of C5b-9 generated during dialysis
also showed a significant positive correlation compared to C5a for all
membranes. (Pearson's correlation coefficient = 0.856, p = 0.0001). I
t is concluded that the two cellulose diacetate membranes are not iden
tical, with the differences observed being a consequence of the degree
of acetyl substitution, resulting in alteration of membrane structure
and the method of sterilization. The clinical significance of these d
ifferences are difficult to characterize but the modification of the c
ellulose structure appears to be a promising method to improve the bio
compatibility of cellulose membranes. The improved biocompatibility of
fered by this method still falls short of that achieved with low flux
synthetic membranes such as Fresenius Polysulfone.